News

Janette Platter is the community chaplain at Saint Luke’s Bishop Spencer Place, a vibrant senior living community just steps from the Country Club Plaza. But in early 2025, she was just another mom seeking the very best care for her child. Fortunately, she knew it wasn’t too far away.

Kirsti Millar, a 35-year-old of Kansas City, was 23 weeks pregnant with her second child in early 2023 when her water suddenly broke. What should have been a season of joy and anticipation became a medical emergency.

Lung cancer is the number one cause of cancer-related death in the United States—and diagnosing the disease early is critical in improving survival rates.

Born with congenital heart disease, 41-year-old Christin Murphy has undergone three heart surgeries to repair pulmonary valves. They have been tough to get through, but Murphy says this latest one at Saint Luke’s changed her outlook.

Alexis Ellington has a renewed outlook on life after being the first Saint Luke's patient to receive a new cancer treatment called Bispecific T-cell Engagers therapy, or BiTE.

BBC News talked to Dr. Mikhail Kosiborod about new findings on the cardiovascular effects of semaglutide.

A new subanalysis presented by Dr. Mikhail Kosiborod shows benefits of semaglutide in patients with atrial fibrillation.

On average, survival benefits of CPR for cardiac arrest could be three times as high for white adults compared to Black adults and twice as high for men compared to women.

Semaglutide improves symptoms in both men and women who present with heart failure. When it comes to weight loss, however, the drug appears to benefit women much more than men.